CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, Stephanie M, Akkari, Leila, Schuhmacher, Alberto J, Bowman, Robert L, Sevenich, Lisa, Quail, Daniela F, Olson, Oakley C, Quick, Marsha L +12 more·2013·Nature Medicine

Cited by (1,005)

Items 501–600 of 1,005

  1. T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems
    Yalong Yang, Fei Yang, Zhuan-qing Huang, Yuan-yuan Li, Hao-yuan Shi, Qi Sun, Yue Ma, Yao Wang, Ying Zhang, Sen Yang et al. · 2023 · Frontiers in Immunology
  2. Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction
    Anne‐Laure Leblond, Kerstin Klinkert, Kenneth Martin, Elizebeth C. Turner, Arun H. S. Kumar, Tara C. Browne, Noel M. Caplice · 2015 · PLoS ONE
  3. Targeting tumor-associated macrophages to combat pancreatic cancer
    Ran Cui, Wen Yue, Edmund C. Lattime, Mark N. Stein, Qing Xu, Xiang‐Lin Tan · 2016 · Oncotarget
  4. The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma
    Irene Soncin, Jianpeng Sheng, Qi Chen, Shihui Foo, Kaibo Duan, Josephine Lum, Michael Poidinger, Francesca Zolezzi, Klaus Karjalainen, Christiane Ruedl · 2018 · Nature Communications
  5. Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment
    Elsa Quintana, Christopher J. Schulze, Darienne R. Myers, Tiffany J. Choy, Kasia Mordec, David P. Wildes, Nataliya Tovbis Shifrin, Amira Belwafa, Elena S. Koltun, Adrian L. Gill et al. · 2020 · Cancer Research
  6. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
    Berenice Ortiz, Armida W. M. Fabius, Wei Wu, Alicia M. Pedraza, Cameron Brennan, Nikolaus D. Schultz, Kenneth L. Pitter, Jacqueline Bromberg, Jason T. Huse, Eric C. Holland et al. · 2014 · Proceedings of the National Academy of Sciences
  7. Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.
    D. Evrard, P. Szturz, A. Tijeras-Raballand, Lucile Astorgues-Xerri, C. Abitbol, V. Paradis, E. Raymond, S. Albert, B. Barry, S. Faivre · 2019 · Oral Oncology
  8. Tumor vessel co-option probed by single-cell analysis.
    Laure-Anne Teuwen, Laura P. M. H. de Rooij, A. Cuypers, Katerina Rohlenova, Sébastien J. Dumas, M. García-Caballero, Elda Meta, J. Amersfoort, Federico Taverna, Lisa M. Becker et al. · 2021 · Cell Reports
  9. The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
    Paul Chaintreuil, Emeline Kerreneur, Maxence Bourgoin, Coline Savy, Cécile Favreau, Guillaume Robert, Arnaud Jacquel, Patrick Auberger · 2023 · Frontiers in Immunology
  10. Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
    Tianhang Li, Tianyao Liu, Wenjie Zhu, Shangxun Xie, Zihan Zhao, Baofu Feng, Hongqian Guo, Rong Yang · 2021 · Clinical Medicine Insights Oncology
  11. EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization
    Xiaoqiong Wei, Song Zou, Zhonghui Xie, Zhen Wang, Nongyu Huang, Zhifu Cen, Yan Hao, Chengxin Zhang, Zhen‐Yu Chen, Fulei Zhao et al. · 2021 · Cardiovascular Research
  12. Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy
    Wenwen Zhao, Zhi Zhang, Mingyuan Xie, Feng Ding, Xiangrong Zheng, Shicheng Sun, Jianyang Du · 2025 · npj Precision Oncology
  13. Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
    Habashy, Karl John, Mansour, Rana, Moussalem, Charbel, Sawaya, Raymond, Massaad, Michel J. · 2022 · British Journal of Cancer
  14. Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations
    Marja K. Lohela, Amy-Jo Casbon, Aleksandra Olow, Lynn Bonham, Daniel G. Branstetter, Ning Weng, Jeffrey Smith, Zena Werb · 2014 · Proceedings of the National Academy of Sciences
  15. Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
    Kshama Gupta, Terry C. Burns · 2018 · Frontiers in Oncology
  16. Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer
    Carlotta Tacconi, Federica Ungaro, Carmen Correale, Vincenzo Arena, Luca Massimino, Michael J. Detmar, Antonino Spinelli, Michele Carvello, Massimiliano Mazzone, Ana Isabel Oliveira et al. · 2019 · Cancer Research
  17. Current Approaches for Glioma Gene Therapy and Virotherapy
    Kaushik Banerjee, Felipe Javier Núñez, Santiago Haase, Brandon L. McClellan, Syed Mohd Faisal, Stephen V. Carney, Jin Yü, Mahmoud S. Alghamri, Antonela Sofía Asad, Alejandro J. Nicola Candia et al. · 2021 · Frontiers in Molecular Neuroscience
  18. The immune landscape of common CNS malignancies: implications for immunotherapy
    Martina Ott, Robert Michael Prins, Amy B. Heimberger · 2021 · Nature Reviews Clinical Oncology
  19. Immune Response to Cancer Therapy: Mounting an Effective Antitumor Response and Mechanisms of Resistance
    Terry R. Medler, Tiziana Cotechini, Lisa M. Coussens · 2015 · Trends in cancer
  20. The role of macrophage phenotype in regulating the response to radiation therapy
    Xiaoshan Shi, Stephen Lawrence Shiao · 2017 · Translational research
  21. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment
    Tong‐Fei Li, Ke Li, Chao Wang, Xin Zhe Liu, Yu Wen, Yong‐Hong Xu, Quan Zhang, Qiu-Ya Zhao, Ming Shao, Yan-Ze Li et al. · 2017 · Journal of Controlled Release
  22. Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution
    Zhaoshi Bao, Yongzhi Wang, Qiangwei Wang, Shengyu Fang, Xia Shan, Jiguang Wang, Tao Jiang · 2021 · Frontiers of Medicine
  23. The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression
    Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna Maria Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco Paolo Cammarata et al. · 2022 · Biomedicines
  24. Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression
    Aleksandra Ellert‐Miklaszewska, P. Wiśniewski, Magdalena Kijewska, Paweł Gajdanowicz, Dominika Pszczolkowska, Piotr Przanowski, Michał Dąbrowski, Marta Maleszewska, B Kaminska · 2016 · Oncogene
  25. The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy
    Erica C. F. Yeo, Michael Paul Brown, Tessa Gargett, Lisa M. Ebert · 2021 · Cells
  26. Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
    Hongmei Zheng, Sumit Siddharth, Sheetal Parida, Xinhong Wu, Dipali Sharma · 2021 · Cancers
  27. Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
    Zengpanpan Ye, Xiaolin Ai, Kailin Yang, Zhengnan Yang, Fan Fei, Xiaoling Liao, Zhixin Qiu, Ryan C. Gimple, Huairui Yuan, Hao Huang et al. · 2023 · Cancer Discovery
  28. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation
    Yi Fan, Alka A. Potdar, Yanqing Gong, Sandeepa M. Eswarappa, Shannon B. Donnola, Justin Durla Lathia, Dolores Hambardzumyan, Jeremy N. Rich, Paul L. Fox · 2014 · Nature Cell Biology
  29. Imaging of anticancer drug action in single cells
    Miller, Miles A., Weissleder, Ralph · 2017 · Nature reviews. Cancer
  30. The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages
    Lingyan Ping, Ning Ding, Yunfei Shi, Lixia Feng, Jiao Li, Yalu Liu, Yufu Lin, Cunzhen Shi, Xing Wang, Zhengying Pan et al. · 2017 · Oncotarget
  31. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms
    Jinming Yang, Amrendra Kumar, Anna E. Vilgelm, Sheau‐Chiann Chen, Gregory Dan Ayers, Sergey V. Novitskiy, Sebastian Joyce, Ann J. Richmond · 2018 · Cancer Immunology Research
  32. Glioblastoma Therapy in the Age of Molecular Medicine
    Luiz Henrique Geraldo, Celina Garcia, Anna Carolina Carvalho da Fonseca, Luiz Gustavo Dubois, Tânia Cristina Leite de Sampaio e Spohr, Diana Matias, Eduardo Sabino de Camargo Magalhães, Rackele Ferreira do Amaral, Bárbara Gomes da Rosa, Izabella Grimaldi et al. · 2018 · Trends in cancer
  33. Microenvironmental Heterogeneity in Brain Malignancies
    Lucas J. M. Perus, Logan A. Walsh · 2019 · Frontiers in Immunology
  34. Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes
    Chunbo Li, Keqin Hua · 2022 · Frontiers in Immunology
  35. Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
    Jian Zhong, Xudong Xing, Yixin Gao, Lei Pei, Chenfei Lu, Huixin Sun, Yanxing Lai, Kang Du, Feizhe Xiao, Ying Yang et al. · 2024 · Cancer Cell
  36. Microglia and brain macrophages: An update
    Atsushi Sasaki · 2016 · Neuropathology
  37. Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma
    Cornelissen, Robin, Lievense, Lysanne A., Maat, Alexander P., Hendriks, Rudi W., Hoogsteden, Henk C., Bogers, Ad J., Hegmans, Joost P., Aerts, Joachim G. · 2014 · PLoS ONE
  38. Macrophage-Mediated Subversion of Anti-Tumour Immunity
    Valeria Quaranta, Michael C. Schmid · 2019 · Cells
  39. Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
    Carlos Velásquez, Sheila Mansouri, Carla Mora, Farshad Nassiri, Suganth Suppiah, Juan Martino, Gelareh Mohammed Zadeh, José L. Fernández-Luna · 2019 · Journal of Oncology
  40. Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics
    Natalia Ochocka, Bozena Kaminska · 2021 · International Journal of Molecular Sciences
  41. Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
    Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain · 2022 · Cancers
  42. Doxycycline Inhibits Polarization of Macrophages to the Proangiogenic M2-type and Subsequent Neovascularization
    Lizhi He, Alexander G. Marneros · 2014 · Journal of Biological Chemistry
  43. Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
    M. Liguori, C. Buracchi, F. Pasqualini, Francesca Bergomas, S. Pesce, M. Sironi, F. Grizzi, A. Mantovani, Cristina Belgiovine, P. Allavena · 2016 · OncoTarget
  44. Advances in immunotherapeutic research for glioma therapy
    Jeremy Tetsuo Miyauchi, Stella E. Tsirka · 2017 · Journal of Neurology
  45. A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis
    Hila Doron, Tobias Pukrop, Neta Erez · 2019 · Cancer Research
  46. Glioblastomas exploit truncated O - linked glycans for local and distant immune modulation via the macrophage galactose-type lectin
    Sophie A. Dusoswa, Jan Verhoeff, Erik R. Abels, Santiago P. Méndez‐Huergo, Diego Omar Croci, Lisan H Kuijper, Elena de Miguel, Valérie M Wouters, Myron G. Best, Ernesto Rodríguez et al. · 2020 · Proceedings of the National Academy of Sciences
  47. Recent Advances in Porphyrin-Based Inorganic Nanoparticles for Cancer Treatment
    Hanieh Montaseri, Cherie Ann Kruger, Heidi Abrahamse · 2020 · International Journal of Molecular Sciences
  48. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
    Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali A. Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar Mujeeb et al. · 2021 · Frontiers in Pharmacology
  49. Roles of STAT3 in the pathogenesis and treatment of glioblastoma
    Weijia Fu, Xue Hou, Lihua Dong, Wei Hou · 2023 · Frontiers in Cell and Developmental Biology
  50. Tumor associated macrophages in gynecologic cancers
    Venkatesh Krishnan, Bruce T. Schaar, Supreeti Tallapragada, Oliver Dorigo · 2018 · Gynecologic Oncology
  51. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression
    Duowei Wang, Xianjing Li, Jiani Li, Yuan Lu, Sen Zhao, Xin‐Ying Tang, Xin Chen, Jiaying Li, Yan Zheng, Shuran Li et al. · 2019 · Gut
  52. Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
    Mengyuan Peng, Niannian Li, Hongbo Wang, Yaxu Li, Hui Liu, Yanhua Luo, Bao Lang, Weihang Zhang, Shilong Li, Liujun Tian et al. · 2025 · MedComm
  53. Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
    Kelly Kersten, Camilla Salvagno, Karin E. de Visser · 2015 · Frontiers in Immunology
  54. Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance
    Mounia Sabrina Braza, Patricia Conde, Mercedes Rodriguez Garcia, Isabel Cortegano, Manisha Brahmachary, Venu Pothula, François Fay, Péter Boros, Sherry Abboud Werner, Florent Ginhoux et al. · 2018 · American Journal of Transplantation
  55. Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding Immunosuppressive Tumor Microenvironment.
    Lei Li, Ming-Ming Zhen, Hao-Yu Wang, Zihao Sun, Wang Jia, Zhong-Pu Zhao, Chen Zhou, Shuai Liu, Chun-Ru Wang, Chun-Li Bai · 2020 · Nano letters (Print)
  56. Advances in Research of Adult Gliomas
    Alina Finch, Georgios Solomou, Victoria Wykes, Ute Pohl, Chiara Bardella, Colin Watts · 2021 · International Journal of Molecular Sciences
  57. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling
    Zheng-Nan Cai, Wan Li, S. Hager, Jayne Louise Wilson, Leila Afjehi-Sadat, Elke H. Heiss, T. Weichhart, P. Heffeter, W. Weckwerth · 2024 · Cellular & Molecular Immunology
  58. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis
    Mamatha Bangalore Nijaguna, Vikas Patil, Serge Urbach, Shivayogi Durgad Shwetha, K. Sravani, Alangar Sathyaranjandas Hegde, Bangalore A. Chandramouli, Arimappamagan Arivazhagan, Philippe Marin, Vani Santosh et al. · 2015 · Journal of Biological Chemistry
  59. Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
    Meredith L. Stone, Gregory Lawrence Beatty · 2019 · Pharmacology & Therapeutics
  60. Generation of Myeloid Cells in Cancer: The Spleen Matters
    Chong Wu, Qiaomin Hua, Limin Zheng · 2020 · Frontiers in Immunology
  61. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
    Jiayi Zeng, Xiangxue Li, Max Sander, Haipeng Zhang, Guangmei Yan, Yuan Lin · 2021 · Frontiers in Immunology
  62. Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment
    Paul Taufalele, Wenjun Wang, Alan J. Simmons, Austin N. Southard-Smith, Bob Chen, Joshua D. Greenlee, Michael R. King, Ken S. Lau, Duane C. Hassane, François Bordeleau et al. · 2022 · Acta Biomaterialia
  63. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
    Chao Lin, Ning Wang, Chengyan Xu · 2023 · Frontiers in Immunology
  64. Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
    Mohammed I. El–Gamal, Shahad K. Al-Ameen, Dania M. Al-Koumi, Mawadda G. Hamad, Nouran A. Jalal, Chang‐Hyun Oh · 2018 · Journal of Medicinal Chemistry
  65. Biology and therapeutic targeting of tumour‐associated macrophages
    Tim Beltraminelli, Michele De Palma · 2020 · The Journal of Pathology
  66. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
    Sharmila Nair, Luciano Mazzoccoli, Arijita Jash, Jennifer Govero, Sachendra S. Bais, Tong Hu, Camila R. Fontes-Garfias, Chao Shan, Hideho Okada, Sujan Shresta et al. · 2020 · JCI Insight
  67. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
    Ali N. Chamseddine, Tarek Assi, Olivier Mir, Salem Chouaı̈b · 2021 · Pharmacology & Therapeutics
  68. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
    Russell Maxwell, Christopher Mitchell Jackson, Michael K. Lim · 2017 · Current Treatment Options in Oncology
  69. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
    Elizabeth Anne Comen, Robert L. Bowman, Maria Kleppe · 2018 · Frontiers in Cell and Developmental Biology
  70. Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas
    Ji Zhang, Meige Guan, Qianliang Wang, Jiajun Zhang, Tianshou Zhou, Xiaoqiang Sun · 2019 · Briefings in Bioinformatics
  71. Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
    Bolei Li, Min Ren, Xuedong Zhou, Qi Han, Lei Cheng · 2020 · Oral Oncology
  72. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
    Ni Tong, Zhenqiang He, Yujie Ma, Zheng Wang, Ziming Huang, Haihong Cao, Lanyang Xu, Yuheng Zou, Wanyu Wang, Chenpeng Yi et al. · 2021 · Frontiers in Cell and Developmental Biology
  73. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
    Qiang Wang, Yong Lu, R. Li, Yanfang Jiang, Yuhuan Zheng, Jianfei Qian, Enguang Bi, Chengyun Zheng, Jian Hou, Sisi Wang et al. · 2017 · Leukemia
  74. PI3Kγ activates integrin α4 promotes immune suppressive myeloid cell polarization during tumor progression
    P. Foubert, Megan M. Kaneda, J. Varner · 2017 · Cancer immunology research
  75. Targeting tumor‐associated macrophages: A potential treatment for solid tumors
    Yibing Chen, Huan Jin, Yucen Song, Ting Huang, Jun Cao, Qing Tang, Zhengzhi Zou · 2020 · Journal of Cellular Physiology
  76. The journey from stem cell to macrophage
    Mikaël J. Pittet, Matthias Nahrendorf, Filip K. Świrski · 2014 · Annals of the New York Academy of Sciences
  77. Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers
    Yoanna Tsvetkova, Nataliia Beztsinna, Maike Baues, Dionne C.G. Klein, Anne Rix, Susanne K. Golombek, Wa’el Al Rawashdeh, Felix Gremse, Matthias Barz, Kaloian Koynov et al. · 2017 · Nano Letters
  78. Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
    H. Grégoire, L. Roncali, A. Rousseau, M. Chérel, Y. Delneste, P. Jeannin, F. Hindré, E. Garcion · 2020 · Frontiers in Pharmacology
  79. Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence
    Spencer S. Watson, Anoek Zomer, Nadine Fournier, João Lourenço, Manfredo Quadroni, Agnieszka Chryplewicz, Sina Nassiri, Pauline Aubel, Simona Avanthay, Davide Croci et al. · 2024 · Cancer Cell
  80. Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits
    Xi Feng, Timothy D. Jopson, Maria Serena Paladini, Sharon Liu, Brian L. West, Nalin M. Gupta, Susanna Rosi · 2016 · Journal of Neuroinflammation
  81. Breast Cancer Induces Systemic Immune Changes on Cytokine Signaling in Peripheral Blood Monocytes and Lymphocytes
    Wang, Lei, Simons, Diana L., Lu, Xuyang, Tu, Travis Y., Avalos, Christian, Chang, Andrew Y., Dirbas, Frederick M., Yim, John H., Waisman, James, Lee, Peter P. · 2020 · EBioMedicine
  82. The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
    Luque-Campos, Noymar, Bustamante-Barrientos, Felipe A., Pradenas, Carolina, García, Cynthia, Araya, María Jesús, Bohaud, Candice, Contreras-López, Rafael, Elizondo-Vega, Roberto, Djouad, Farida, Luz-Crawford, Patricia et al. · 2021 · Frontiers in Immunology
  83. Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation
    Natália Rodrigues Mantuano, Michal A. Stanczak, Isadora de Araújo Oliveira, Nicole Kirchhammer, Alessandra A. Filardy, Gianni Monaco, Ronan Christian Santos, Agatha Carlos Fonseca, Miguel Fontes, César de Souza Bastos et al. · 2020 · Cancer Immunology Research
  84. A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
    Adele M. Alchahin, Shenglin Mei, Ιωάννα Τσέα, Taghreed Hirz, Youmna Sami Kfoury, Douglas M. Dahl, Chin‐Lee Wu, Alexander O. Subtelny, Shulin Wu, David T. Scadden et al. · 2022 · Nature Communications
  85. Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy
    Yuzhu Hu, Wen Nie, Liang Lyu, Xifeng Zhang, Wanyu Wang, Yunchu Zhang, Shi He, Anjie Guo, Fei Liu, Bilan Wang et al. · 2024 · ACS Nano
  86. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells
    Min Hee Yang, Bo Ma, Hanshuang Shao, Amanda M. Clark, Alan H. Wells · 2016 · BMC Cancer
  87. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme
    Yunyun Liu, Xiaoyu Li, Yuanpei Zhang, Hongxuan Wang, Xiongming Rong, Jialing Peng, Lei He, Ying Peng · 2019 · Oncogene
  88. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
    Elaheh Nasrollahzadeh, Sepideh Razi, Mahsa Keshavarz‐Fathi, Massimiliano Mazzone, Nima Rezaei · 2020 · Cancer Immunology Immunotherapy
  89. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition
    Rohit Rao, Rong Han, Sean Ogurek, Chengbin Xue, Lai Man Natalie Wu, Liguo Zhang, Li Zhang, JIAN LI HU, Timothy N. Phoenix, Stephen N. Waggoner et al. · 2021 · Neuro-Oncology
  90. Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli
    Yishan Chuang, Michelle E. Hung, Brianne K Cangelose, Joshua N. Leonard · 2016 · Innate Immunity
  91. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression
    Ashleigh R. Poh, Christopher G. Love, Frédérick Masson, Adele Preaudet, Cary Tsui, Lachlan W. Whitehead, Simon P. Monard, Yelena Khakham, Lotta Burstroem, Guillaume Lessène et al. · 2017 · Cancer Cell
  92. CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages
    Antonin Papin, Benoît Tessoulin, Céline Bellanger, Anne Moreau, Yannick Le Bris, Hervé Maisonneuve, Philippe Moreau, Cyrille Touzeau, Martine Amiot, Catherine Pellat‐Deceunynck et al. · 2019 · Leukemia
  93. Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
    Karoline Kielbassa-Elkadi, Serena Vegna, Christel F. A. Ramirez, Leila Akkari · 2019 · Frontiers in Immunology
  94. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
    Fiona A. Desland, Adı́lia Hormigo · 2020 · International Journal of Molecular Sciences
  95. CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model
    I‐Li Tan, Raquel Duque do Nascimento Arifa, Harikrishna Rallapalli, Veronika Kana, Zhimin Lao, Reeti Mayur Sanghrajka, Nermin Sumru Bayin, Antoine J. Tanne, Alexandre Wojcinski, Andrey Korshunov et al. · 2020 · Oncogene
  96. Tumor‐Associated Macrophage‐Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC‐I Expression
    Junjun Li, Keshan Wang, Chao Yang, Kai Zhu, Cheng Jiang, Minjie Wang, Zijie Zhou, Nan Tang, Qiangping Wang, Siqi Wang et al. · 2023 · Advanced Science
  97. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis
    Susanta Pahari, Shikha Negi, Mohammad Aqdas, Eusondia Arnett, Larry S. Schlesinger, Javed Naim Agrewala · 2019 · Autophagy
  98. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
    Seok‐Beom Yong, Jee Young Chung, Yoonsung Song, Jaehyun Kim, Sehee Ra, Yong‐Hee Kim · 2019 · Biomaterials
  99. CSF1 overexpression has pleiotropic effects on microglia in vivo
    Ishani De, Mária Nikodémová, Megan D. Steffen, Emily Sokn, Vilena I. Maklakova, Jyoti J. Watters, Lara S. Collier · 2014 · Glia
  100. Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma
    Mu Yang, Zhenhua Li, Meijing Ren, Shuai Li, Lanjing Zhang, Xinmin Zhang, Fangfang Liu · 2018 · Journal of Cancer